Back to Search Start Over

Refractory epilepsy and nonadherence to drug treatment.

Authors :
Henning O
Lossius MI
Lima M
Mevåg M
Villagran A
Nakken KO
Johannessen Landmark C
Source :
Epilepsia open [Epilepsia Open] 2019 Nov 06; Vol. 4 (4), pp. 618-623. Date of Electronic Publication: 2019 Nov 06 (Print Publication: 2019).
Publication Year :
2019

Abstract

In patients with epilepsy, nonadherence to agreed antiepileptic drug (AED) treatment may result in seizure relapse, and at worst sudden unexpected death. The aim of this study was to examine the extent of both unintentional and intentional nonadherence among Norwegian patients with refractory epilepsy and try to identify possible risk factors. At the National Centre for Epilepsy in Norway, 333 consecutive adult in- and outpatients with refractory epilepsy participated in an anonymous survey about adherence to drug treatment. Twenty-two percentages admitted that they sometimes or often forgot to take their drugs as scheduled, and 19% reported that they, rarely, sometimes or often intentionally did not follow the AED treatment plan agreed upon with their physician. Young age and depression were significantly correlated with unintentional nonadherence. Intentional nonadherence was associated with young age (36 years or younger). We found nonadherence not to be associated with any specific AED. In conclusion, about one-fifth of patients with refractory epilepsy admitted that they did not adhere to the agreed drug treatment plan, either intentionally or unintentionally. Measures to reduce nonadherence in this patient group may improve seizure control and should be tailored to address both unintentional and intentional lack of adherence.<br />Competing Interests: Dr Henning has served as a paid consultant for Eisai, UCB, and LivaNova, outside the submitted work. Dr Lossius has served as a paid consultant for ESAI and UCB, outside the submitted work. The remaining authors have no conflicts of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.<br /> (© 2019 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy.)

Details

Language :
English
ISSN :
2470-9239
Volume :
4
Issue :
4
Database :
MEDLINE
Journal :
Epilepsia open
Publication Type :
Academic Journal
Accession number :
31819918
Full Text :
https://doi.org/10.1002/epi4.12367